More Moderate Risk Patients Pick Contralateral Prophylactic Mastectomy
Many patients who chose mastectomy were not at increased breast-cancer risk and may have done so based on a failed attempt at breast-conservation surgery.
Read More
Dose Fulvestrant Escalation Increase Breast Cancer Progression?
Doubling the dose of fulvestrant increases the time to disease progression in the treatment of postmenopausal women with breast cancer.
Optimal Extent of Neoadjuvant Letrozole to Permit Breast Conservation
About 10 months of neoadjuvant letrozole is optimal for breast-conserving surgery in patients with early breast cancer.
Fewer Lung Cancer Deaths Seen in Patients on Anti-Estrogen Therapies
Lung cancer deaths are significantly less common in breast cancer patients who are treated with anti-estrogens.
Tamoxifen Has Favorable Effect on Recurrences in DCIS
A study reveals a beneficial effect of tamoxifen on breast cancer recurrences at 10 and 15 years of follow-up in women with ductal carcinoma in situ (DCIS).